In summary, our findings suggest that resveratrol diminishes inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease by reinstating autophagic lysosomal flux through the AKT/TMEM175 pathway. Here, TMEM175 is linked to interstitial lung disease.